GBT
VRTX icon

Grove Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Grove Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
2,525
-122
-5% -$54.1K 0.12% 102
2026
Q1 		$1.18M Buy
2,647
+563
+27% +$263K 0.13% 99
2025
Q4 		$945K Buy
2,084
+1,645
+375% +$709K 0.11% 124
2025
Q3 		$172K Sell
439
-26
-6% -$10.9K 0.02% 264
2025
Q2 		$207K Sell
465
-15
-3% -$6.91K 0.03% 244
2025
Q1 		$233K Buy
480
+7
+1% +$3.26K 0.03% 222
2024
Q4 		$190K Buy
473
+63
+15% +$29.2K 0.03% 224
2024
Q3 		$191K Buy
410
+22
+6% +$10.6K 0.03% 227
2024
Q2 		$182K Sell
388
-14
-3% -$6.08K 0.03% 229
2024
Q1 		$168K Hold
402
– – 0.03% 245
2023
Q4 		$164K Sell
402
-4
-1% -$1.48K 0.03% 236
2023
Q3 		$141K Sell
406
-132
-25% -$46.2K 0.03% 244
2023
Q2 		$189K Sell
538
-12
-2% -$4.04K 0.04% 219
2023
Q1 		$173K Buy
550
+32
+6% +$9.6K 0.04% 226
2022
Q4 		$150K Buy
+518
New +$158K 0.03% 237
2018
Q1 		– Sell
-55
Closed -$8K – 451
2017
Q4 		$8K Sell
55
-65
-54% -$9.62K ﹤0.01% 458
2017
Q3 		$18K Hold
120
– – 0.01% 410
2017
Q2 		$15K Buy
120
+65
+118% +$7.82K 0.01% 412
2017
Q1 		$6K Hold
55
– – ﹤0.01% 406
2016
Q4 		$4K Buy
+55
New +$4.47K ﹤0.01% 498

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Grove Bank & Trust's VRTX Position: Q2 2026 in Review

Grove Bank & Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 4.6% in Q2 2026, selling an estimated $54.1K and leaving 2,525 shares worth $1.25M. The position accounts for 0.12% of the portfolio, ranked #102.

Grove Bank & Trust first reported a position in VRTX in Q4 2016 and has held it in 20 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Grove Bank & Trust held 2,525 shares of Vertex Pharmaceuticals worth $1.25M as of Q2 2026.
  • Grove Bank & Trust sold 122 Vertex Pharmaceuticals shares in Q2 2026, an estimated $54.1K.
  • Vertex Pharmaceuticals made up 0.12% of Grove Bank & Trust's portfolio in Q2 2026, its #102 holding.
  • Grove Bank & Trust first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 20 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.